Company Updates
Mobotech Update June 2016: US Showcases & Demonstrations Continue; Last Investment Round Still Available
Another busy month showcasing and demonstrating the Mobots around the US. Greg Ecker (President, Magline) and Steve Haythorne presented the Mobot to the 3PL & Chief Supply Chain Managers Summit in Chicago. This event was attended by 400+ senior logistic, retailer and manufacturing managers as a means to keep pace with innovation and meet with industry […]
Universal Biosensors 1H 2016 Financial Results Webcast
13th July 2016, ASX Announcement Universal Biosensors (ASX:UBI) will be hosting an investor webcast to discuss the 2016 Half Year Financial Results on Thursday, 21 July 12.00pm noon AEST. The call will be hosted by Universal Biosensors Executive Chairman Andrew Denver. Shareholders are invited to register for the live webcast of the Half Year results […]
PANALITIX Unique Accounting Application Now Available at Intuit Marketplace
12th July 2016, Yahoo Finance PANALITIX, the global leader of a subscription-based community for accountants and financial advisors, recently announced its availability at the Intuit Marketplace, a longstanding aggregate market of best in industry software to enhance a variety of business functions. PANALITIX software syncs with QuickBooks Online, Xero, and MYOB accounting solutions. In conjunction with […]
DomaCom FY16 Update: $12m Raising in Pre-IPO Funding, $250m Crowd-Funding Campaign Launched, IPO Prospectus
DomaCom Limited, owner of Australia’s first regulated fractional property investment fund, has been well received by Australian investors, raising $12m in pre-IPO funding over the past 18 months. DomaCom has demonstrated the versatility of its revolutionary investment model when it launched a $250m crowd-funding campaign to buy the iconic pastoral empire S Kidman & Co, Australia’s largest landholding. The […]
QBiotics FY16 Update: $16m Raised, New Appointments to Board, Preparation for Further Registrations
The last 12 months has seen QBiotics strengthen both its board and balance sheet. Over the last 12 months, the company has raised $16m and will soon raise a further $10m, giving them a balance sheet of approx $30m. These funds will be used to further develop their two drug products EBC-46 (cancer) and WH-1 […]
Analytica Receive FDA Approval for Over the Counter Clearance PeriCoach
12th July 2016, ASX Announcement Analytica Ltd (ASX: ALT) is pleased to announce that the US Food and Drug Administration (FDA) has granted the company over-the-counter (OTC) clearance for the PeriCoach system, previously available in the US by prescription only. The PeriCoach is a unique medical device that assists women to exercise their pelvic floor […]
Cellmid FY16 Update: Strong Revenue Growth, Full Range Launched, Presence Built in Major Markets
Cellmid, a life sciences accelerator, continued to build its consumer health business during FY2016 and is on track to deliver strong revenue growth for the period. The Company launched its full range of clinically validated hair growth products, evolis®, in Australian pharmacies in May 2015, and doubled its Japanese distribution. Most recently, Cellmid launched an […]
Avenir Capital FY16 Update: Portfolio Grew by 30%, Delivered Gross Returns of 17%, Attractive Long-Term Returns for Investors
Avenir Capital, has now been operating for 5 years and delivered gross returns of 17% per annum. The companies in our current portfolio grew operating income, on average, by 30% in 2015 (median growth of 25%) and have continued that growth in 2016. The portfolio trades at what we believe to be attractive prices of […]
Jetpack Aviation FY16 Update: JB-9 Jetpack Unveiled, Global Media Coverage, US Military R&D Projects
In November 2015, Jetpack Aviation unveiled its JB-9 Jetpack to the world’s via a demonstration flight around the Statue of Liberty in New York. The JB-9 is a jet engine powered Jetpack weighing just 45kgs. After the flight the company received significant global coverage media including a feature in the Wall St Journal, the Gadget […]
Backed By Leading Investment Groups and Family Offices
